Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Cancer|December 15, 1993
National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survivalH N Nguyen, H E Averette, W Hoskins, et al.
Journal of Clinical Pathology|January 1, 1976
EB virus antibody and infectious mononucleosis in a boarding school for boysT W Hoskins, W B Fletcher, J M Blake, et al.
Cancer|November 15, 1993
National survey of ovarian carcinoma. VI. Critical assessment of current International Federation of Gynecology and Obstetrics staging systemH N Nguyen, H E Averette, W Hoskins, et al.
Cancer|January 15, 1994
National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patientsR D Hightower, H N Nguyen, H E Averette, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 31, 2025
Isoquercetin and Zafirlukast Cooperatively Suppress Tumor Growth and Thromboinflammatory Signaling in a Xenograft Model of Ovarian CancerJustine A Keovilay, Jason W Hoskins, Jean-Pierre Kinet, et al.
Acta Medica Austriaca|January 1, 1989
Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience)M Markman, B Reichman, T Hakes, et al.
Gynecologic Oncology|August 6, 2000
Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignanciesA Husain, J Curtin, C Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancerM Markman, T Hakes, B Reichman, et al.
The Yale Journal of Biology and Medicine|July 1, 1989
Intraperitoneal therapy in the management of ovarian carcinomaM Markman, T Hakes, B Reichman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 1991
Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatinM Markman, B Reichman, T Hakes, et al.
Pageof 9